Page 154 - ESHRE2019

• Li J., Gao Y., Guan L. et al. Discovery of phosphatidic acid, phoshatidylcholine, and phosphatidylserine as biomarkers of early diagnosis of endometriosis. Front. Physiol. 2018, 9:14.
• Liu E., Nisenblat V., Farquhar C. et al. Urinary biomarkers fo the non‐invasive diagnosis of endometriosis, Cochrane Database of Systematic Reviews, 2015, 12, CD012019.
• May K.E., Conduit‐Hulbert S.A., Villar J. et al. Peripheral biomarkes of endometriosis: a systematic review, Hum. Reprod. Update, 2010, 16, 6, 651‐674.
• Nisenblat V., Bossuyt P.M.M. Shaikh R. et al. Blood biomarkers for the non‐invasive diagnosis of endometriosis, Cochrane Database of Systematic Reviews 2016; 5, CD012179.
• Omenn G.S., Lane L., Overall C.M. et al. Progress on identifying and characterizing the Human proteome: 2018 metrics from the HUPO Human proteome project, J. Proteome Res. 2018, 17, 4031‐ 4041.
• Patti. G. J., Yanes O., Siuzdak G. Metabolomics: the apogee of the omics trilogy. Nature Rev. in Mol. Cell Biol. 2012, 13, 263‐269.
• Quehenberger O., Armando A.M., Brown A.H. et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipids Research 2010, 51, 3299‐3305.
• Rizner T.L. Non‐invasive biomarkers of endometriosis: myth or reality, Expert. Rev. Mol. Diagn. 2014, 14, 3, 365‐385.
• Rizner T.L., Adamski J. Paramount importance of sample quality in pre‐clinical and clinical research‐
Need for standard operating procedures J. Steroid. Biochem. Mol. Biol. 2019, 186, 1‐3.
43
• Rizner T.L., Sassano H., Cho M.H. et al. Recommendations for description and validation of antibodies for research use. J. Steroid Biochem. Mol. Biol. 2016, 156, 40‐42.
• Rogers P.A.W, Adamson G.D., Al‐Jefout M. et al. Research priorities for endometriosis: recommendations from a global consortium of investigators in endometriosis, Reprod. Sci. 2017, 24,2, 202‐226.
• Savino R., Paduano S., Preiano M. Terracciano R. The proteomics big challenge for biomarkers and new drug‐targets discovery. Int. J. Mol. Sci. 2012, 13, 13926‐13948.
• Schwenk J.M., Omenn G.S., Sun Z. et al. The human plasma proteome draft of 2018: building on the human plasma peptide atlas from mass spectrometry and complementary assays. J. Proteome Res. 2017, 16, 4299‐4310.
• Simoens S., Dunselman G., Dirkens C. et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum. Reprod. 2012, 27, 1292‐1299.
• Vouk K., Hevir N., Ribič‐Pucelj M. et al. Discovery of phosphatidylcholines and sphinogmyelins as biomarkers for ovarian endometriosis. Hum. Reprod. 2012, 27, 10, 2955‐2965.
• Vouk K., Ribič‐Pucelj M., Adamski J. et al. Altered levels of acylcarnitines, phosphatidylcholines, and sphingomyelines in peritoneal fluid from ovarian endometriosis patients. J. Steroid. Biochem. Mol. Biol. 2016, 159, 60‐69.
• Wishart D.S., Feunang Y.D., Marcu A. et al. HMDB 4.0: the human metabolome database for 2018, Nucleic Acids Res., 2018, 46, D608‐D617.
• Zhao M., Li M., Yang Y. et al. A comprehensive analysis and annotation of human normal urinary
proteome Sci. Reports 2017, 7:3024.
44
152
149